Literature DB >> 9776456

Photochemotherapy of experimental colonic tumours with intra-tumorally applied methylene blue.

K Orth1, D Russ, G Beck, A Rück, H G Beger.   

Abstract

INTRODUCTION: Phototoxicity of intra-tumoral injected methylene blue (MB+) was studied in 48 experimental colonic tumours in comparison with photosan-3, Zn-phthalocyanine and tetrasulphanated ClAl-phthalocyanine.
METHODS: In mice. xenotransplanted subcutaneous tumours about 1 cm in diameter were treated photodynamically twice, with different sensitisers. The irradiation was performed at the sensitiser-specific wavelength, and a density of 100 mW/cm2 and a dose of 100 J/cm2.
RESULTS: Light alone without sensitiser did not induce any effect in mice tumours. Surprisingly, Al-phthalocyanine could only be used for intratumoral injections because of toxic effects after intravenous applications in nude mice. Using MB+ (1%), 75% of the tumours were destroyed by a single photodynamic treatment (PDT). In addition, toxicity of MB+ was most intense when compared with Zn-phthalocyanine and photosan-3. However, after the second PDT, there was no statistically significant difference among these sensitisers. Dark toxicity of MB+ (1%) could be well demonstrated by sufficient sensitiser incorporation without irradiation, which led to a stationary tumour volume up to 3 weeks after injection.
CONCLUSION: Intra-tumoral MB+ PDT is a potential treatment for inducing necrosis in vivo. With regard to tumour tissue, the selectivity of MB+ is high and depends on a precise local injection of the dye.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776456     DOI: 10.1007/s004230050132

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  6 in total

1.  Methylene blue mediated photobiomodulation on human osteoblast cells.

Authors:  Gamze Bölükbaşı Ateş; Ayşe Ak; Bora Garipcan; Murat Gülsoy
Journal:  Lasers Med Sci       Date:  2017-08-04       Impact factor: 3.161

2.  Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals.

Authors:  Thomas H Foster; Benjamin R Giesselman; Rui Hu; Malcolm E Kenney; Soumya Mitra
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

3.  Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue.

Authors:  Timothy M Baran; Benjamin R Giesselman; Rui Hu; Merrill A Biel; Thomas H Foster
Journal:  Lasers Surg Med       Date:  2010-10       Impact factor: 4.025

4.  Methylene blue covalently loaded polyacrylamide nanoparticles for enhanced tumor-targeted photodynamic therapy.

Authors:  Ming Qin; Hoe Jin Hah; Gwangseong Kim; Guochao Nie; Yong-Eun Koo Lee; Raoul Kopelman
Journal:  Photochem Photobiol Sci       Date:  2011-04-09       Impact factor: 3.982

5.  Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma.

Authors:  Nevien A Samy; Manal M Salah; Maha F Ali; Ahmed M Sadek
Journal:  Lasers Med Sci       Date:  2014-07-17       Impact factor: 3.161

6.  Photodynamic inactivation of drug-resistant bacteria isolated from diabetic foot ulcers.

Authors:  N Kashef; G Esmaeeli Djavid; M Siroosy; A Taghi Khani; F Hesami Zokai; M Fateh
Journal:  Iran J Microbiol       Date:  2011-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.